Munich - Delayed Quote EUR

Tandem Diabetes Care Inc (TD5A.MU)

20.51

-0.34

(-1.63%)

As of 8:00:15 AM GMT+2. Market Open.

TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its non-GAAP loss of $0.67 per share was 9.5% below analysts’ consensus estimates.

StockStory 22 hours ago

TNDM
Exploring 3 Undervalued Small Caps With Insider Action Across Regions

In the last week, the United States market has remained flat, though it has seen an 8.0% increase over the past year with earnings forecasted to grow by 14% annually. In this environment, identifying small-cap stocks that are perceived as undervalued and have notable insider activity can offer unique opportunities for investors seeking potential growth.

Simply Wall St. 3 days ago

MITK

TNDM

NFE
3 of Wall Street’s Favorite Stocks in Dangerous Territory

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

StockStory 3 days ago

FDX

TNDM

MYGN
Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO, May 06, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

Business Wire 8 days ago

TNDM
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.

Zacks 13 days ago

TNDM
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Tandem Diabetes Care ( NASDAQ:TNDM ) First Quarter 2025 Results Key Financial Results Revenue: US$234.4m (up 22% from...

Simply Wall St. 13 days ago

TNDM
Q1 2025 Tandem Diabetes Care Inc Earnings Call

Q1 2025 Tandem Diabetes Care Inc Earnings Call

Thomson Reuters StreetEvents 13 days ago

TNDM
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...

Tandem Diabetes Care Inc (TNDM) reports robust growth and strategic advancements, while navigating competitive pressures and operational challenges.

GuruFocus.com 14 days ago

TNDM
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 14 days ago

TNDM
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.

StockStory 14 days ago

TNDM
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -11.67% and 6.44%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 14 days ago

TNDM
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.

StockStory 14 days ago

TNDM
Tandem Diabetes Care Announces First Quarter 2025 Financial Results

SAN DIEGO, April 30, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025.

Business Wire 14 days ago

TNDM
What to Expect From These 3 MedTech Stocks This Earnings Season?

Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.

Zacks 16 days ago

ICLR

ALGN

TNDM
Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results tomorrow after the bell. Here’s what you need to know.

StockStory 16 days ago

TNDM
1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

StockStory 23 days ago

TNDM

NVMI
Reasons to Hold TNDM Stock in Your Portfolio for Now

A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.

Zacks 28 days ago

TNDM
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

StockStory 30 days ago

TNDM

PHR

EVH
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. Let's consider two examples: Teladoc Health (NYSE: TDOC) and Tandem Diabetes Care (NASDAQ: TNDM). Teladoc Health, a telemedicine specialist, might not feel a substantial direct impact from Trump's tariffs.

Motley Fool last month

TDOC

TNDM
3 Undervalued Small Caps With Recent Insider Activity Across Regions

In the midst of significant market volatility, with major indices like the Dow and Nasdaq experiencing sharp declines following a brief rally, investors are increasingly focused on small-cap stocks as potential opportunities. The S&P 600 index for small-cap stocks has been particularly influenced by recent economic uncertainties and tariff developments, highlighting the importance of identifying companies that demonstrate resilience and potential for growth. In such an environment, a good...

Simply Wall St. last month

THRY

TNDM

MTLS

Performance Overview

Return	TD5A.MU	S&P 500 (^GSPC)
YTD	-42.34%	-0.14%
1-Year	-49.85%	+10.65%
3-Year	-69.70%	+45.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Tandem Diabetes Care Inc (TD5A.MU)

TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures

Exploring 3 Undervalued Small Caps With Insider Action Across Regions

3 of Wall Street’s Favorite Stocks in Dangerous Territory

Tandem Diabetes Care Announces Upcoming Conference Presentations

TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Q1 2025 Tandem Diabetes Care Inc Earnings Call

Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars

Tandem Diabetes Care Announces First Quarter 2025 Financial Results

What to Expect From These 3 MedTech Stocks This Earnings Season?

Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For

1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar

Reasons to Hold TNDM Stock in Your Portfolio for Now

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Performance Overview